Interesting ImagesHepatic Vascular Malformation Mimics PSMA-Positive Prostate Cancer MetastasisHoberück, Sebastian MD*; Driesnack, Sebastian*; Seppelt, Danilo MD†; Michler, Enrico MD*; Hölscher, Tobias MD‡,§; Kotzerke, Jörg MD*Author Information From the Departments of *Nuclear Medicine †Radiology ‡Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden §OncoRay–National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden–Rossendorf, Dresden, Germany. Received for publication August 23, 2019; revision accepted February 16, 2020. Conflicts of interest and sources of funding: none declared. Correspondence to: Sebastian Hoberück, MD, Department of Nuclear Medicine, Faculty of Medicine and University Hospital Carl Gustav Carus, TU, Dresden, Fetscherstr. 74, 01307 Dresden, Germany. E-mail: Sebastian.Hoberueck@uniklinikum-dresden.de. Online date: April 23, 2020 Clinical Nuclear Medicine: June 2020 - Volume 45 - Issue 6 - p e283-e284 doi: 10.1097/RLU.0000000000003032 Buy Metrics Abstract An 80-year-old man developed high-risk prostate cancer after 7 years of active surveillance. For staging and treatment planning, a 68Ga-PSMA PET/MRI was performed. Besides the PSMA-positive primary tumor and a solitary bone metastasis in the fifth thoracic vertebral body, an intensive intrahepatic PSMA expression (SUVmax, 16.3) was suspicious for a liver metastasis. The results of a previously performed contrast-enhanced CT, a consecutively performed contrast-enhanced ultrasound, and a follow-up PSMA PET/CT after 4 months with a stable lesion during androgen deprivation lead to the diagnosis of a vascular malformation metabolically mimicking a hepatic metastasis of the prostate tumor. Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.